Correspondence 0001213900-26-068521 from Onconetix, Inc. (ONCO)
Onconetix, Inc.
Date: June 15, 2026 · CIK: 0001782107 · Accession: 0001213900-26-068521
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-296615
Letter
Onconetix, Inc.
201 E. Fifth Street, Suite 1900
Cincinnati, OH 45202
VIA EDGAR
June 15, 2026
U.S. Securities and Exchange Commission
Office of Life Sciences
Washington, D.C. 20549
Attn: Tim Buchmiller
Re: Onconetix, Inc.
Registration Statement on Form S-1
Filed June 9, 2026
File No. 333-296615
Ladies and Gentleman,
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Onconetix, Inc. hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4:30 p.m. EST on Tuesday, June 16, 2026, or as soon as thereafter practicable.
Very truly yours,
/s/ David Allan White
Show Raw Text
CORRESP 1 filename1.htm Onconetix, Inc. 201 E. Fifth Street, Suite 1900 Cincinnati, OH 45202 VIA EDGAR June 15, 2026 U.S. Securities and Exchange Commission Office of Life Sciences Washington, D.C. 20549 Attn: Tim Buchmiller Re: Onconetix, Inc. Registration Statement on Form S-1 Filed June 9, 2026 File No. 333-296615 Ladies and Gentleman, Pursuant to Rule 461 under the Securities Act of 1933, as amended, Onconetix, Inc. hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4:30 p.m. EST on Tuesday, June 16, 2026, or as soon as thereafter practicable. Very truly yours, /s/ David Allan White By: David Allan White Title: Chief Executive Officer cc: Ellenoff Grossman & Schole LLP